These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 20739614)
1. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614 [TBL] [Abstract][Full Text] [Related]
2. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712 [TBL] [Abstract][Full Text] [Related]
3. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466 [TBL] [Abstract][Full Text] [Related]
4. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump. Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742 [TBL] [Abstract][Full Text] [Related]
5. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device. Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921 [TBL] [Abstract][Full Text] [Related]
6. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. Crow S; Milano C; Joyce L; Chen D; Arepally G; Bowles D; Thomas W; Ortiz NV ASAIO J; 2010; 56(5):441-5. PubMed ID: 20613494 [TBL] [Abstract][Full Text] [Related]
8. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). Klovaite J; Gustafsson F; Mortensen SA; Sander K; Nielsen LB J Am Coll Cardiol; 2009 Jun; 53(23):2162-7. PubMed ID: 19497443 [TBL] [Abstract][Full Text] [Related]
9. Platelet dysfunction in outpatients with left ventricular assist devices. Steinlechner B; Dworschak M; Birkenberg B; Duris M; Zeidler P; Fischer H; Milosevic L; Wieselthaler G; Wolner E; Quehenberger P; Jilma B Ann Thorac Surg; 2009 Jan; 87(1):131-7. PubMed ID: 19101285 [TBL] [Abstract][Full Text] [Related]
10. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients. Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067 [TBL] [Abstract][Full Text] [Related]
11. Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients. Joyce D; Crow S; Li Z; Joyce L; Milano C; Rogers J; Villamizar-Ortiz N; Chen D J Heart Lung Transplant; 2012 Jul; 31(7):750-6. PubMed ID: 22538169 [TBL] [Abstract][Full Text] [Related]
12. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II. Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469 [TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Malehsa D; Meyer AL; Bara C; Strüber M Eur J Cardiothorac Surg; 2009 Jun; 35(6):1091-3. PubMed ID: 19303790 [TBL] [Abstract][Full Text] [Related]
14. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices. Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734 [TBL] [Abstract][Full Text] [Related]
15. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart. Reich HJ; Morgan J; Arabia F; Czer L; Moriguchi J; Ramzy D; Esmailian F; Lam L; Dunhill J; Volod O J Thromb Haemost; 2017 Aug; 15(8):1620-1624. PubMed ID: 28586149 [TBL] [Abstract][Full Text] [Related]
17. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart. Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153 [TBL] [Abstract][Full Text] [Related]
18. Immediate recovery of acquired von Willebrand syndrome after left ventricular assist device explantation: implications for heart transplantation. Davis ME; Haglund NA; Tricarico NM; Matafonov A; Gailani D; Maltais S ASAIO J; 2015; 61(1):e1-4. PubMed ID: 25251586 [TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support. Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475 [TBL] [Abstract][Full Text] [Related]
20. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]